Building the future of
human communication.
We are creating a new way to connect with the world, and each other. River is building a speech neuroprosthesis that refuses to trade between signal and safety, to restore and augment the human experience.
For anything further, get in touch.
Team & Advisors
Oseh MathiasFounderRepeat Founder. MedTech. Materials Science. AI. Neuroscience. Silicon.
Dr. David EaglemanAdvisorNeuroscientist. Professor at Stanford. Investor. Repeat Neurotech Founder.
Dr. Christian HerffScienceFirst to decode continuous speech from the cortical surface. Maastricht University.
Dr. Sam JohnPreclinicalHelped bring Synchron to first-in-human trials. Neural Engineering, University of Melbourne.
Claire WhiteOps ManagerClinical Operations Manager at Roche. Business operations at Google Health. Computer Science and Molecular Biology at MIT.
Board
Backed By
Clinical
Dr Gillian ZavosSpeech PathologyCertified practising speech pathologist. 25 years in disordered speech.
Legal
Partners
Surgical Navigation
Bench & Hardware
Regulatory Affairs
Clinical & Research
Clinical Trials
Our first clinical study is in preparation. Sites, eligibility, and timing will be published on our website once the protocol is registered.
To hear about participation when recruitment opens, register your interest.


